Health

Alys Pharmaceuticals Begins Phase IIa Trial for ALY-101 in Alopecia Areata

The pioneering immuno-dermatology company has announced the successful dosing of the first patient in its Phase IIa clinical trial for ALY-101, a novel treatment for Alopecia Areata.

Training the Immune System to Outlast Cancer

Personalized RNA vaccines show long-term promise in pancreatic cancer, new study reports.

The Liver's Hidden Protector: How a Brain Protein Could Revolutionise MASH Treatment

New research reveals NWD1's critical role in preventing liver disease by regulating calcium and ER stress, offering a new target for drug development

Lifestyle and Environment Matter More Than Genes in Determining Longevity

Recent research has revealed that environmental and lifestyle factors play a far greater role in determining health outcomes and longevity than genetic predisposition, casting light on the age old "nature vs. nurture" debate.

Biodegradable Drug Delivery Systems

We examine the advancements in sustainable drug delivery and their potential impacts to the world of healthcare.

Patch Made From Lab-Grown Muscle Can Repair Damaged Hearts

Scientists have successfully implanted lab-grown heart muscle into primates and, for the first time, a human patient.